EMcision
EMcision 的各类消融导管在经内镜逆行胰胆管造影(ERCP)治疗方面处于全球领先及创新地位。

EMcision Limited was founded by internationally renowned surgeon and inventor of medical devices, Professor Nagy Habib, to develop proprietary medical devices based on proven RF technology for the surgical community. Devices for endoscopists and interventional radiologists soon followed.

The Company combines scientific, commercial and management skills, brought together in a working partnership to develop and commercialize medical devices that are clinically relevant, cost-effective and enhance the quality of life of cancer patients.

Headquartered at Imperial College London with clinical activities based at the Hammersmith campus and engineering facilities in Hitchin, the company is backed by a small group of investors, including the Imperial College London University Challenge Seed Fund.

Mission

To enhance cancer patients’ quality of life by applying empathy to precision.

To advance surgical and medical techniques by harnessing the power and accuracy of radiofrequency energy for specific applications in percutaneous procedures and open, laparoscopic, vascular and endoscopic surgeries.

To deliver innovation without boundaries by bridging academic, R&D, engineering and commercial areas of expertise with real-world clinical experience, and by developing distribution opportunities that make EMcision products available worldwide.